Category: ~$2.49B

  • Coloplast to Acquire Atos Medical for ~$2.49B

    Shots: Coloplast to acquire Atos Medical for an enterprise value of $2.49B from PAI Partners. The transaction is expected to close in Q2’22 Coloplast obtains access to a new chronic care segment to be run as a separate strategic business unit operating on shared Coloplast infrastructure that also supports its offerings in urology, continence and […]